our products
Contact phone

Tradjenta

Diabetes Tradjenta (Generic) Generic drugs, marketed without brand names, contain the exact same active ingredients used in their brand-name counterparts, but cost significantly less. The drugs are required to meet US Food and Drug Administration (FDA) standards for safety, purity and effectiveness.
Tradjenta

Tradjenta (linagliptin) is a diabetic medication that may be used orally and helps to keep blood sugar levels under control. It accomplishes this by controlling the amount of insulin that is produced by your body in response to eating. Adults who have type 2 diabetes mellitus can improve their management of their blood sugar by using tradjenta in conjunction with changes to their diet and physical activity.

BEST DEAL!

Save 20% with

Coupon "PKVCbYFj9G"

The Benefits of Linagliptin (Tradjenta)

Introduction

In the world of diabetes management, there are various medications available to help individuals control their blood sugar levels. One such medication is Linagliptin, commonly known by its brand name Tradjenta. Linagliptin is a prescription drug that belongs to a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. In this blog post, we will explore the benefits of Linagliptin and how it can improve the lives of those living with diabetes.

Effective Blood Sugar Control

One of the primary benefits of Linagliptin is its ability to effectively control blood sugar levels in individuals with type 2 diabetes. By inhibiting DPP-4, Linagliptin helps increase the levels of incretin hormones in the body, such as GLP-1 and GIP. These hormones stimulate the release of insulin and reduce the production of glucagon, resulting in lower blood glucose levels. Studies have shown that Linagliptin can significantly reduce HbA1c levels, which is a long-term measure of blood sugar control.

Cardiovascular Benefits

Apart from its blood sugar-lowering effects, Linagliptin has also shown cardiovascular benefits. In a landmark clinical trial called CARMELINA, it was found that Linagliptin did not increase the risk of major cardiovascular events in adults with type 2 diabetes who had a high risk of cardiovascular disease. This is an important finding, as cardiovascular disease is a common complication associated with diabetes. The study demonstrated that Linagliptin is a safe and effective option for individuals with diabetes who are at risk of cardiovascular events.

Weight Neutrality

Weight gain is a common concern for individuals with diabetes who are taking certain medications. However, one of the advantages of Linagliptin is its weight neutrality. Unlike some other diabetes medications, Linagliptin does not typically cause weight gain or increase appetite. This can be particularly beneficial for individuals who are already overweight or obese and are looking to manage their weight as part of their diabetes management plan.

Conclusion

Linagliptin, marketed as Tradjenta, is a valuable medication for individuals with type 2 diabetes. Its ability to effectively control blood sugar levels, coupled with its cardiovascular benefits and weight neutrality, make it an attractive option for diabetes management. However, it is important to consult with a healthcare professional before starting any new medication to determine if Linagliptin is the right choice for you. Remember, managing diabetes is a multifaceted approach, and medication is just one piece of the puzzle.

Testimonials

high quality medications

Free discreet shipping

Secure online transactions

Money-back guarantee

Fast worldwide delivery

By staying on our site you automatically agree with the storage and processing of your personal data, in accordance with our Privacy Policy.